Simplify Propel Opportunities ETF Holdings
SURI was created on 2023-02-08 by Simplify. The fund's investment portfolio concentrates primarily on target outcome asset allocation. SURI employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities. Derivatives may also be used to leverage exposure and hedge against declines.
Last Updated: 3 days, 6 hours ago
Last reported holdings - Simplify Propel Opportunities ETF
Ticker | Name | Est. Value |
---|---|---|
PAGP
|
PLAINS GP HLDGS L P | $24.7 million |
Cash
|
Cash | $11.1 million |
AKRO
|
AKERO THERAPEUTICS INC USD 0.0001 | $6.1 million |
PHAT
|
PHATHOM PHARMACEUTICALS USD 0.0001 | $2.8 million |
TELSAT 6.5 10.15.27 144A
|
TELSAT 6 1/2 10/15/27 Corp | $2.5 million |
ABEO
|
ABEONA THERAPEUTICS INC USD 0.01 | $2.5 million |
APLT
|
APPLIED THERAPEUTICS INC USD 0.0001 | $1.8 million |
TCRX
|
TSCAN THERAPEUTICS INC USD 0.0001 | $1.7 million |
SNDX
|
SYNDAX PHARMACEUTICALS I USD 0.0001 | $1.6 million |
TELSAT 5.625 12.06.26 144A
|
TELSAT 5 5/8 12/06/26 Corp | $1.6 million |
DCTH
|
DELCATH SYS INC USD 0.01 | $1.4 million |
CMPX
|
COMPASS THERAPEUTICS INC USD 0.0001 | $1.4 million |
MIST
|
MILESTONE PHARMACEUTICALS INC NPV | $1.1 million |
MAAT.PA
|
MAAT PHARMA SACA EUR 0.1 | $952907 |
ZVRA
|
ZEVRA THERAPEUTICS INC USD 0.0001 | $864000 |
ACHV
|
ACHIEVE LIFE SCIENCES INC USD 0.001 | $518471 |
ATHA
|
ATHIRA PHARMA INC USD 0.0001 | $438880 |
EIGRQ
|
EIGER BIOPHARMACEUTICALS USD 0.0001 | $423000 |
None
|
CONTRA CHINOOK THERAPE + NPV | $38500 |
Recent Changes - Simplify Propel Opportunities ETF
Date | Ticker | Name | Change (Shares) |
---|